WSR 20-23-060
(Health Technology Clinical Committee)
[Filed November 16, 2020, 9:02 a.m.]
The health technology clinical committee reached a final coverage decision for the following technologies at their July 10, 2020, public meeting:
Tinnitus: Noninvasive, nonpharmacologic treatments*
Decision No. 20200515A
Vagal nerve stimulation for depression and epilepsy*
Decision No. 20200515B
* Final coverage decision previously reported as June 12, 2020.
Stem cell therapy for musculoskeletal conditions
Decision No. 20200612A
All documents related to these evidence assessments, including the final coverage decisions, are available on the health technology assessment program website
For further information contact Christine Masters, Program Specialist, WA - Health Technology Assessment, P.O. Box 626, 8th Avenue S.E., Olympia, WA 98504-2712, desk 360-725-5126, fax 360-586-8827,